TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 21nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 29nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 33nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 33nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 36nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 36nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 37nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 38nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 38nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 39nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 41nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 42nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 42nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 51nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 54nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 58nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 76nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 89nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 94nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 2 (strain HG52) (HHV-2) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 140nMAssay Description:Inhibitory activity of the compound against Varicella Zoster Virus (VZV) herpes protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Epstein-Barr virus (strain B95-8) (HHV-4) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 180nMAssay Description:Inhibitory activity against cytomegalovirus (CMV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 180nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 2 (strain HG52) (HHV-2) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 2 (strain HG52) (HHV-2) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 2 (strain HG52) (HHV-2) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Epstein-Barr virus (strain B95-8) (HHV-4) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 210nMAssay Description:Inhibitory activity against cytomegalovirus (CMV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 2 (strain HG52) (HHV-2) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 210nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Epstein-Barr virus (strain B95-8) (HHV-4) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 220nMAssay Description:Inhibitory activity against cytomegalovirus (CMV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Epstein-Barr virus (strain B95-8) (HHV-4) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 230nMAssay Description:Inhibitory activity against cytomegalovirus (CMV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 2 (strain HG52) (HHV-2) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 230nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Epstein-Barr virus (strain B95-8) (HHV-4) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibitory activity against cytomegalovirus (CMV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 2 (strain HG52) (HHV-2) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 2 (strain HG52) (HHV-2) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 2 (strain HG52) (HHV-2) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 260nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 2 (strain HG52) (HHV-2) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 270nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Epstein-Barr virus (strain B95-8) (HHV-4) (Human h...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 280nMAssay Description:Inhibitory activity against cytomegalovirus (CMV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human herpesvirus 6A (strain Uganda-1102) (HHV-6 v...)
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 290nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair